Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN388750 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-5'-Nucleotidase, Ecto (CD73) (NT5E) (AA 520-550), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 520-550, C-Term
- Antibody clone number
- RB02846
- Vial size
- 400 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots.
- Handling
- Avoid freeze-thaw cycles.
Submitted references Myo5b knockout mice as a model of microvillus inclusion disease.
Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.
RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells.
Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry.
Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury.
A simplified method for the preparation of detergent-free lipid rafts.
Cartón-García F, Overeem AW, Nieto R, Bazzocco S, Dopeso H, Macaya I, Bilic J, Landolfi S, Hernandez-Losa J, Schwartz S Jr, Ramon y Cajal S, van Ijzendoorn SC, Arango D
Scientific reports 2015 Jul 23;5:12312
Scientific reports 2015 Jul 23;5:12312
Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Zhi X, Wang Y, Yu J, Yu J, Zhang L, Yin L, Zhou P
IUBMB life 2012 Nov;64(11):911-20
IUBMB life 2012 Nov;64(11):911-20
Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.
Hart ML, Grenz A, Gorzolla IC, Schittenhelm J, Dalton JH, Eltzschig HK
Journal of immunology (Baltimore, Md. : 1950) 2011 Apr 1;186(7):4367-74
Journal of immunology (Baltimore, Md. : 1950) 2011 Apr 1;186(7):4367-74
RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells.
Zhi X, Wang Y, Zhou X, Yu J, Jian R, Tang S, Yin L, Zhou P
Cancer science 2010 Dec;101(12):2561-9
Cancer science 2010 Dec;101(12):2561-9
Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry.
Leth-Larsen R, Lund R, Hansen HV, Laenkholm AV, Tarin D, Jensen ON, Ditzel HJ
Molecular & cellular proteomics : MCP 2009 Jun;8(6):1436-49
Molecular & cellular proteomics : MCP 2009 Jun;8(6):1436-49
Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury.
Hart ML, Henn M, Köhler D, Kloor D, Mittelbronn M, Gorzolla IC, Stahl GL, Eltzschig HK
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008 Aug;22(8):2784-97
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008 Aug;22(8):2784-97
A simplified method for the preparation of detergent-free lipid rafts.
Macdonald JL, Pike LJ
Journal of lipid research 2005 May;46(5):1061-7
Journal of lipid research 2005 May;46(5):1061-7
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC